TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30819707

Group type: EXPERIMENTAL
Intervention: Online, computerised memory specificity training (c-MeST) programme for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 28291545

Group type: EXPERIMENTAL
Intervention: Bevacizumab (B) + single agent chemotherapy (CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single agent chemotherapy (CT)
Number of subjects: 0
Study: 25565364

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of 0.5 mg dutasteride and 0.4 mg tamsulosin
Number of subjects: 742

Group type: COMPARATOR
Intervention: Watchful waiting with protocol-defined initiation of tamsulosin therapy if symptoms did not improve (WW-All)
Number of subjects: 742
Study: 23885709

Group type: COMPARATOR
Intervention: OVAL survey for estimating sun exposure
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Geraldton survey (gold standard) for estimating sun exposure
Number of subjects: 90

Group type: COMPARATOR
Intervention: OVAL survey for estimating vitamin D exposure
Number of subjects: 90
Study: 21775681

Group type: EXPERIMENTAL
Intervention: Rituximab (anti-CD20 monoclonal antibody), administered as four weekly doses.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19030182

Group type: EXPERIMENTAL
Intervention: Darifenacin
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Darifenacin plus Behavioral Modification Program
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: OAB-SAT-q
Number of subjects: 375
Study: 17542980

Group type: EXPERIMENTAL
Intervention: Variable pulsed light (VPL)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Light-emitting diode (LED)
Number of subjects: 25
Study: 15447886

Group type: EXPERIMENTAL
Intervention: Sensory-specific satiety measured after ad libitum lunch
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Taste (sweet or savory)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Appetite ratings after lunch
Number of subjects: 44
Study: 11433853

Group type: EXPERIMENTAL
Intervention: Midazolam (mean dose, 8.6 mg)
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: Midazolam plus additional midazolam as needed (mean total dose, 12.2 mg)
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: Fentanyl (1.4 micrograms/kg) plus midazolam (mean dose, 5.7 mg)
Number of subjects: 997

Group type: EXPERIMENTAL
Intervention: Fentanyl (1.4 micrograms/kg), midazolam (mean dose, 5.8 mg) and methohexital as needed (mean dose, 61.0 mg)
Number of subjects: 997

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 997
Study: 9730384

Group type: EXPERIMENTAL
Intervention: Percutaneous acetic acid injection (50% acetic acid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Percutaneous ethanol injection (absolute ethanol)
Number of subjects: 60
Study: 8049833

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sleep fragmentation
Number of subjects: 8
Study: 3885181

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ticarcillin and Tobramycin
Number of subjects: 30
Study: 31904855

Group type: EXPERIMENTAL
Intervention: IVIG (0.4 g/kg/d) for five consecutive days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 30257794

Group type: EXPERIMENTAL
Intervention: Surgeon control of fluoroscope activation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Technologist control of fluoroscope activation
Number of subjects: 73
Study: 27538468

Group type: EXPERIMENTAL
Intervention: Miniaturized cardiopulmonary bypass systems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional cardiopulmonary bypass systems
Number of subjects: 0
Study: 24739906

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine mouth rinse
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combination mouth rinse (0.03% triclosan, 0.05% sodium fluoride, and 5% xylitol)
Number of subjects: 30
Study: 23056361

Group type: EXPERIMENTAL
Intervention: Slow breathing with biofeedback; n=15
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Slow breathing without biofeedback; n=15
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group; n=15
Number of subjects: 46
Study: 20839152

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 18626028

Group type: EXPERIMENTAL
Intervention: Integrated care intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 64
Study: 17113780

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both Diltiazem and Amiodarone
Number of subjects: 30
Study: 15359583

Group type: EXPERIMENTAL
Intervention: 2, 5, 10, or 25 mg tadalafil
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 11938824

Group type: EXPERIMENTAL
Intervention: Defibrase injection (DI)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Acanthopanax injection (AI)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ginaton injection (GI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 64
Study: 8957976

Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg kg‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: vecuronium 0.1 mg kg‐1
Number of subjects: 20
Study: 1389316

Group type: EXPERIMENTAL
Intervention: Immunoglobulin (Endobulin, Immuno) administered intravenously at a dose of 100 mg/kg/week during the first 3 months, followed by 2 x 200 mg/kg/month during the 4th, 5th, and 6th months
Number of subjects: 60

Group type: COMPARATOR
Intervention: No immunoglobulin administered
Number of subjects: 60
Study: 3898410

Group type: EXPERIMENTAL
Intervention: Isoxicam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 0
Study: 31800470

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30732583

Group type: EXPERIMENTAL
Intervention: Comprehensive interventions focused on treatment intensification and adherence improvement.
Number of subjects: 648

Group type: COMPARATOR
Intervention: Control group based on randomized selection from the SIDIAP database.
Number of subjects: 648
Study: 27443526

Group type: EXPERIMENTAL
Intervention: Extra Virgin Olive Oil (EVOO), 50 ml daily for 3 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Refined Olive Oil (ROO), 50 ml daily for 3 weeks
Number of subjects: 23
Study: 27002934

Group type: EXPERIMENTAL
Intervention: Intravenous rucaparib (intermittent dosing schedule)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Oral rucaparib (across all six dose levels)
Number of subjects: 44
Study: 24373376

Group type: EXPERIMENTAL
Intervention: PRK with adjuvant mitomycin-C (MMC)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Epithelial laser in situ keratomileusis (epi-LASIK)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both PRK-MMC and epi-LASIK
Number of subjects: 13
Study: 22868016

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg (maximum of 8 mg)
Number of subjects: 100
Study: 19324976

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 160
Study: 17507612

Group type: EXPERIMENTAL
Intervention: Exercise intervention (45 min, 5 days/week moderate-intensity sports/recreational exercise)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Stretching control group
Number of subjects: 173
Study: 14961167

Group type: EXPERIMENTAL
Intervention: MDK-group (supplement with minerals and vitamin D plus vitamin K1)
Number of subjects: 181

Group type: COMPARATOR
Intervention: MD-group (supplement with minerals and vitamin D)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 181

Group type: COMPARATOR
Intervention: MD-group vs Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: MDK-group vs Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 181
Study: 11903917

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 57

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 57
Study: 9627208

Group type: EXPERIMENTAL
Intervention: Anticonvulsant monotherapy (200mg CBZ, 500mg VPA, 100mg PHT)
Number of subjects: 23
Study: 11224254

Group type: EXPERIMENTAL
Intervention: Buprenorphine 4mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Buprenorphine (both doses)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3115662

Group type: EXPERIMENTAL
Intervention: Inhaled carbon dioxide (CO2) at constant flow into a breathing circuit
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled carbon dioxide (CO2) during exercise
Number of subjects: 11
Study: 28421355

Group type: EXPERIMENTAL
Intervention: Elombe ('Champion') standard operating procedure (SOP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No SOP (comparison)
Number of subjects: 36
Study: 27225736

Group type: EXPERIMENTAL
Intervention: Balneotherapy (21 sessions of spa treatment with 34.8 °C thermomineral water, 5 days a week)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Education alone (control group)
Number of subjects: 66
Study: 24722839

Group type: EXPERIMENTAL
Intervention: CHG‐containing adhesive film dressings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non‐antimicrobial control film dressings
Number of subjects: 0
Study: 24152852

Group type: EXPERIMENTAL
Intervention: K‐712 (phytonutrient), 1 tab twice a day for one week/month
Number of subjects: 122

Group type: COMPARATOR
Intervention: Itraconazole 200 mg orally once a week
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: K‐712 (phytonutrient)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 122
Study: 20838286

Group type: EXPERIMENTAL
Intervention: Intracoronary mononuclear bone marrow cell (BMC) transplantation (1 × 10^8 cells)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (similar patients without BMC transplantation)
Number of subjects: 73
Study: 18546325

Group type: COMPARATOR
Intervention: (1)H‐MRS analysis pretreatment
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: (1)H‐MRS analysis posttreatment (1 year) in hepatic patients
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: (1)H‐MRS analysis posttreatment (1 year) in neurological patients
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: (1)H‐MRS analysis during neurological deterioration
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: (1)H‐MRS analysis during liver failure exacerbation
Number of subjects: 17
Study: 17187094

Group type: EXPERIMENTAL
Intervention: Cryopreserved bone tissue
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bone tissue preserved in 98% glycerol solution at room temperature
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Microbiological analysis of 98% glycerol solution and bone fragments
Number of subjects: 10
Study: 11865133

Group type: EXPERIMENTAL
Intervention: Entacapone treatment for 2 months
Number of subjects: 65
Study: 10369080

Group type: EXPERIMENTAL
Intervention: Quality of life assessment prior to recurrence
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Quality of life assessment immediately after diagnosis of recurrence
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Quality of life assessment at follow-up 6 months later
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Self-reported physical symptoms
Number of subjects: 69
Study: 8566940

Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 744
Study: 2194280

Group type: EXPERIMENTAL
Intervention: Captopril treatment for 9 days in 15 patients with diabetic nephropathy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Enalapril treatment for 8 weeks in 40 patients with diabetic nephropathy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Metoprolol treatment for 8 weeks in 40 patients with diabetic nephropathy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Long-term treatment with captopril in patients with diabetic nephropathy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Furosemide treatment adjusted for blood-pressure control in both groups
Number of subjects: 55
Study: 318049

Group type: EXPERIMENTAL
Intervention: Periocular injection of penicillin combined with multiple preoperative applications of topical chloramphenicol‐sulphadimidine
Number of subjects: 6618

Group type: COMPARATOR
Intervention: Topical chloramphenicol‐sulphadimidine
Number of subjects: 6618

Group type: COMPARATOR
Intervention: Periocular penicillin alone
Number of subjects: 6618
Study: 31873859

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg once daily
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg once daily
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 169
Study: 30668332

Group type: EXPERIMENTAL
Intervention: Wu chu yu tang (WCYT) 3.0 g three times per day for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once per day and WCYT placebo (3.0 g) three times per day for 4 weeks
Number of subjects: 90
Study: 27365318

Group type: EXPERIMENTAL
Intervention: Internet-based, individually tailored smoking cessation program (the Coach)
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Control group (comprehensive Internet smoking cessation website only)
Number of subjects: 1120
Study: 25824001

Group type: EXPERIMENTAL
Intervention: Everolimus plus octreotide LAR
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo plus octreotide LAR
Number of subjects: 429
Study: 23245537

Group type: EXPERIMENTAL
Intervention: Sertraline or Bupropion for 8 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control subjects (no treatment)
Number of subjects: 18
Study: 21092939

Group type: EXPERIMENTAL
Intervention: Cognitive Exercises (CE)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cognitive Package (Cogpack)
Number of subjects: 39
Study: 19460102

Group type: EXPERIMENTAL
Intervention: L-NAME (180 microg kg(−1)h(−1))
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia
Number of subjects: 7
Study: 17310385

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg/day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 15277911

Group type: COMPARATOR
Intervention: SEVO all group
Number of subjects: 200

Group type: COMPARATOR
Intervention: SEVO pre group
Number of subjects: 200

Group type: COMPARATOR
Intervention: SEVO post group
Number of subjects: 200

Group type: COMPARATOR
Intervention: propofol group
Number of subjects: 200
Study: 11357068

Group type: EXPERIMENTAL
Intervention: Secure(2) Medical Adhesive
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Secure(2) Medical Adhesive (reapplication)
Number of subjects: 21
Study: 9202557

Group type: EXPERIMENTAL
Intervention: High-energy transurethral microwave thermotherapy (TUMT)
Number of subjects: 30
Study: 7886584

Group type: EXPERIMENTAL
Intervention: Norplant users for more than 2 years
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (25 female blood donors)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Norplant users for 5 years
Number of subjects: 92
Study: 2878034

Group type: EXPERIMENTAL
Intervention: Intra-operative parenteral gentamicin and vancomycin (with streptomycin in the irrigating solution)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 29294963

Group type: EXPERIMENTAL
Intervention: Male-perpetrated aggression (severe and non-severe)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Bystander intervention in cases of male-perpetrated aggression
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Qualitative responses regarding aggression
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Qualitative responses regarding bystander intervention
Number of subjects: 562
Study: 30845949

Group type: EXPERIMENTAL
Intervention: Health Integrator with monthly health coaching sessions
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Health Integrator only
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 209
Study: 26600170

Group type: EXPERIMENTAL
Intervention: Visual art production
Number of subjects: 113

Group type: COMPARATOR
Intervention: Cognitive art evaluation
Number of subjects: 113
Study: 25803348

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids combined with antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids as monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 0
Study: 23643289

Group type: COMPARATOR
Intervention: Healthy feet
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Flatfoot deformity
Number of subjects: 44
Study: 22139679

Group type: EXPERIMENTAL
Intervention: SHINBARO (purified extract from a mixture of 6 oriental herbs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celecoxib (selective COX-2 inhibitor)
Number of subjects: 0
Study: 19880473

Group type: EXPERIMENTAL
Intervention: Nurse-initiated care (experimental group)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 103
Study: 16813532

Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 1488
Study: 15625331

Group type: EXPERIMENTAL
Intervention: Coronary-artery revascularization before surgery
Number of subjects: 510

Group type: COMPARATOR
Intervention: No revascularization before surgery
Number of subjects: 510
Study: 10752936

Group type: EXPERIMENTAL
Intervention: NEI‐VFQ (National Eye Institute Visual Function Questionnaire)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: NEI‐VFQ subscales
Number of subjects: 244
Study: 8883754

Group type: EXPERIMENTAL
Intervention: Vaginal gemeprost pessaries every 3 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vaginal gemeprost pessaries every 6 hours
Number of subjects: 0
Study: 1556674

Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ibuprofen 2400 mg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ibuprofen (both doses)
Number of subjects: 45
Study: 3920599

Group type: EXPERIMENTAL
Intervention: Clinoril (Sulindac sulphoxide)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3432173

Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride (90 mg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nifedipine (40 mg/day)
Number of subjects: 39
Study: 31995262

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 107
Study: 31295199

Group type: EXPERIMENTAL
Intervention: Conventional hearing aids using wide dynamic range compression
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Hearing aids with frequency translation
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Hearing aids with linear frequency transposition
Number of subjects: 114
Study: 28990651

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) - three exercise sessions per week for 4 weeks, with weekly maintenance sessions if surgery was delayed.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT).
Number of subjects: 53

Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIT) and Usual care (control).
Number of subjects: 53
Study: 26149712

Group type: EXPERIMENTAL
Intervention: Pomalidomide plus low-dose dexamethasone (POM + LoDEX)
Number of subjects: 455

Group type: COMPARATOR
Intervention: High-dose dexamethasone (HiDEX)
Number of subjects: 455
Study: 23316791

Group type: EXPERIMENTAL
Intervention: Functional treatment plus whole body vibration (WBV) during supervised physical therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Functional treatment (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Functional treatment plus WBV
Number of subjects: 60
Study: 21644804

Group type: EXPERIMENTAL
Intervention: Individual treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conjoint treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice of treatment modality
Number of subjects: 0
Study: 17682943

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17072690

Group type: EXPERIMENTAL
Intervention: ACOMA new circle
Number of subjects: 82

Group type: COMPARATOR
Intervention: ACOMA conventional circle
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Fabius new circle
Number of subjects: 82

Group type: COMPARATOR
Intervention: Fabius conventional circle
Number of subjects: 82

Group type: COMPARATOR
Intervention: NM-GS
Number of subjects: 82
Study: 14592564

Group type: EXPERIMENTAL
Intervention: Plasma adiponectin level in CAD group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Plasma adiponectin level in control group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with creatinine in CAD group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with HDL cholesterol in CAD group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with BMI in CAD group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with glucose in CAD group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Correlation of plasma adiponectin with triglycerides in CAD group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Logistic regression model for adiponectin concentration
Number of subjects: 99
Study: 11021553

Group type: EXPERIMENTAL
Intervention: 750 rads of intraoperative beta radiation (group 1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No supplementation (group 2)
Number of subjects: 65
Study: 9113222

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0